| Q32 BIO INC. O.N. |
| USA |
| Gesundheit |
| US7469641051 / A4ZZ0Z |
| DB0 (Frankfurt) / QTTB (NASDAQ) |
| FRA:DB0, ETR:DB0, DB0:GR, NASDAQ:QTTB |
| - |
| https://www.q32bio.com/ |
|
Q32 Bio Inc. is a clinical-stage biotechnology company developing biologic therapeutics that target potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. Its primary focus is on be..
>Volltext.. |
| 103.29 Mio. EUR |
| 71.41 Mio. EUR |
| 46.17 Mio. EUR |
| 18.7 Mio. EUR |
| 28.56 Mio. EUR |
| 2.3 EUR |
| 11.72 Mio. EUR |
| 43.6 Mio. EUR |
| - |
| 4.76 |
| - |
| - |
| - |
| - |
| - |
| - |
| Q32 BIO |
| 27.05.26 |